Alcoholic Intoxication, Chronic
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
To further elucidate the role of TACR1 in affective disorders, rs3771829 was genotyped in a second BPAD sample of 593 subjects (UCL2), in 997 subjects with ADS, and a subsample of 143 individuals diagnosed with BPAD and comorbid alcohol dependence (BPALC). rs3771829 was associated with BPAD (UCL1 and UCL2 combined: P = 2.0 × 10(-3)), ADS (P = 2.0 × 10(-3)) and BPALC (P = 6.0 × 10(-4)) compared with controls screened for the absence of mental illness and alcohol dependence.
|
24817687 |
2014 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
PSYGENET |
After binding to the neurokinin-1 (NK-1) receptor, SP regulates many pathophysiological functions in the central nervous system, such as emotional behavior, stress, depression, anxiety, emesis, vomiting, migraine, alcohol addiction, seizures and neurodegeneration.
|
24705689 |
2014 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
PSYGENET |
The association with TACR1 and BPAD, ADS, and ADHD suggests a shared molecular pathophysiology between these affective disorders.
|
24817687 |
2014 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
PSYGENET |
Genetic deletion or antagonism of the neurokinin 1 receptor (NK1R) decreases alcohol intake, alcohol reward, and stress-induced alcohol relapse in rodents, while TACR1 variation is associated with alcoholism in humans.
|
23419547 |
2013 |
Alcoholic Intoxication, Chronic
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Each of the 5 SNPs in the TACR1 gene that was significantly related to AD severity in the SAGE data set and/or the BOLD response to the craving task is near the 3' or 5' areas of the gene and may therefore be near mutations with potential functional significance.
|
23078527 |
2013 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
PSYGENET |
Each of the 5 SNPs in the TACR1 gene that was significantly related to AD severity in the SAGE data set and/or the BOLD response to the craving task is near the 3' or 5' areas of the gene and may therefore be near mutations with potential functional significance.
|
23078527 |
2013 |
Alcoholic Intoxication, Chronic
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Four single-nucleotide polymorphisms (rs3771829, rs3771833, rs3771856, and rs1701137) at the TACR1 gene, previously known to be associated with bipolar disorder or alcoholism, were strongly associated with ADHD.
|
19204064 |
2010 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
CTD_human |
Four single-nucleotide polymorphisms (rs3771829, rs3771833, rs3771856, and rs1701137) at the TACR1 gene, previously known to be associated with bipolar disorder or alcoholism, were strongly associated with ADHD.
|
19204064 |
2010 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
PSYGENET |
Four single-nucleotide polymorphisms (rs3771829, rs3771833, rs3771856, and rs1701137) at the TACR1 gene, previously known to be associated with bipolar disorder or alcoholism, were strongly associated with ADHD.
|
19204064 |
2010 |
Alcoholic Intoxication, Chronic
|
0.550 |
GeneticVariation
|
disease |
BEFREE |
Taken together, we conclude that polymorphisms of NK1R are significantly associated with the development of AD in Caucasian individuals.
|
19553914 |
2009 |
Alcoholic Intoxication, Chronic
|
0.550 |
Biomarker
|
disease |
BEFREE |
Thus, as assessed by these surrogate markers of efficacy, NK1R antagonism warrants further investigation as a treatment in alcoholism.
|
18276852 |
2008 |
Bipolar Disorder
|
0.520 |
Biomarker
|
disease |
PSYGENET |
The association with TACR1 and BPAD, ADS, and ADHD suggests a shared molecular pathophysiology between these affective disorders.
|
24817687 |
2014 |
Bipolar Disorder
|
0.520 |
Biomarker
|
disease |
BEFREE |
The association with TACR1 and BPAD, ADS, and ADHD suggests a shared molecular pathophysiology between these affective disorders.
|
24817687 |
2014 |
Bipolar Disorder
|
0.520 |
GeneticVariation
|
disease |
BEFREE |
Four single-nucleotide polymorphisms (rs3771829, rs3771833, rs3771856, and rs1701137) at the TACR1 gene, previously known to be associated with bipolar disorder or alcoholism, were strongly associated with ADHD.
|
19204064 |
2010 |
Bipolar Disorder
|
0.520 |
Biomarker
|
disease |
CTD_human |
Four single-nucleotide polymorphisms (rs3771829, rs3771833, rs3771856, and rs1701137) at the TACR1 gene, previously known to be associated with bipolar disorder or alcoholism, were strongly associated with ADHD.
|
19204064 |
2010 |
Bipolar Disorder
|
0.520 |
Biomarker
|
disease |
PSYGENET |
Four single-nucleotide polymorphisms (rs3771829, rs3771833, rs3771856, and rs1701137) at the TACR1 gene, previously known to be associated with bipolar disorder or alcoholism, were strongly associated with ADHD.
|
19204064 |
2010 |
Bipolar Disorder
|
0.520 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder.
|
19415819 |
2009 |
Neurogenic Inflammation
|
0.500 |
Biomarker
|
disease |
CTD_human |
Proliferation of sensory C-fibers and subsequent neurogenic inflammation in rat airway induced by inhaled lipopolysaccharide.
|
21570423 |
2011 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
|
19204064 |
2010 |
Neurogenic Inflammation
|
0.500 |
Biomarker
|
disease |
RGD |
These findings suggest that SP acts via the NK-1 receptor to provoke neurogenic inflammation, oxidative stress, and ICAM-1 expression after OSE in rats.
|
18326823 |
2008 |
Neurogenic Inflammation
|
0.500 |
Biomarker
|
disease |
CTD_human |
Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation.
|
17257769 |
2007 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.
|
11433347 |
2001 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.
|
9748515 |
1998 |
Hyperalgesia
|
0.330 |
Biomarker
|
phenotype |
BEFREE |
In contrast, NK1R antagonism decelerated lesional development and improved hyperalgesia.
|
30689856 |
2019 |
Hyperalgesia
|
0.330 |
Biomarker
|
phenotype |
BEFREE |
Emerging evidence has suggested that neurokinin 1 receptor (NK1R) is important in the development of visceral pain and hyperalgesia, however, whether NK1R exists in the CSF‑CN and its exact role in visceral pain remain to be fully elucidated.
|
28440440 |
2017 |